Comprehensive Oncology Clinical Trials Solutions

Oncology trials require an oncology CRO with a robust scientific team, deep regulatory knowledge, compassionate understanding of, and dedication to improving the patient experience, as well as the expertise to support clinical sites and investigators in recruiting patients and ensuring their safety. In addition, our regulatory affairs team is critical for our sponsors to navigate the ever-changing regulatory environment in oncology. Ergomed has built a substantial track record in oncology, with a history of over 500 studies and 30,000 patients recruited, demonstrating our significant focus and expertise in this field, particularly in early-phase trials.

Cell and gene therapy are becoming increasingly common in oncology and rare diseases. It brings with it specific regulatory requirements, submission processes, and operational challenges. Ergomed has unparalleled experience delivering cell and gene therapy trials in these fields.

Ergomed has the experience and expertise in cell and gene therapy trials to deliver a study setup that is adaptable enough to meet the flexibility required for collecting patients’ cells and closely overseeing shipments, Investigational Medicinal Product (IMP) work, and return to the patient in the shortest possible time.

Our patient toolkit and site management team come into their own when collecting patients’ cells for analysis at specialty laboratories. They always go the extra mile to keep these precious samples safe and ensure patient safety is at the forefront while executing seamlessly.

For the additional regulatory processes for Advanced Therapy Medicinal Products (ATMPs), our internal processes and agile teams will set up the logistics to meet the needs of your unique trial and support patient care.

Ergomed’s unique patient-centric approach, flexibility, and highly effective site management model allow our project teams to support patients and their families, the clinical site, and the sponsor. We understand the importance of each individual in the clinical trial process and strive to make them feel valued and understood.

The success of oncology trials hinges on seamless collaboration between the sponsor, oncology CRO, and clinical sites. Our veteran project management team, each member with an average of over 15 years of clinical trial experience, expertly navigates the complexities of modern oncology trials, including adaptive and umbrella/basket trials, to deliver a seamless patient and sponsor experience.

Ergomed excels in collaborative trial management, ensuring rapid data collection and analysis, accurate reporting of dose-limiting toxicities, and swift dose-escalation decisions, all with patient safety as the top priority. Our approach guarantees that the entire team works together efficiently to achieve study objectives.

Ergomed’s success in delivering complex oncology trials is rooted in our effective site management model. We provide comprehensive support for recruitment, logistics, and medical initiatives, all tailored to meet the specific needs of each site. Our site managers work alongside oncology clinical monitors to reduce logistical hurdles, ensure patient safety, and maintain high-quality standards at all sites.

Ergomed’s proven delivery record, expertise, and true partnership mean our sponsors can trust us to deliver their oncology trials regardless of size or complexity. Oncology trials make up 32% of our study portfolio, and we have treated more than 32,000 patients in more than 470 oncology studies.